Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of diclofenac gel and EMLA ointment for venipuncture pain
IRCT201008234618N1Phase 3Completed
- Sponsor
- Khalili Biotech
- Start
- Apr 2010
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of diclofenac and lidocaine + prilocaine in procedural pain (2 arms), sponsored by Khalili Biotech. Primary endpoint: Pain severity during venipuncture for vein catheter insertion. Started Apr 2010; status: completed.
02
Drugs
diclofenaclidocaine + prilocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on IRCT201008234618N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201008234618N1.